Xtx Topco LTD Assembly Biosciences, Inc. Transaction History

Xtx Topco LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.65 - $1.25 $10,540 - $20,270	16,216 Added 64.25%	41,453 $33,000
Q3 2023 Nov 13, 2023	BUY	$0.87 - $1.13 $21,956 - $28,517	25,237 New	25,237 $22,000
Q2 2022 Aug 15, 2022	BUY	$1.35 - $2.29 $17,829 - $30,244	13,207 New	13,207 $28,000
Q1 2022 May 13, 2022	SELL	$1.46 - $2.45 $35,660 - $59,841	-24,425 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$2.13 - $3.46 $52,025 - $84,510	24,425 New	24,425 $57,000
Q2 2021 Aug 12, 2021	SELL	$3.8 - $4.56 $43,510 - $52,211	-11,450 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$4.33 - $6.63 $49,578 - $75,913	11,450 New	11,450 $53,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $714M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.